Shi C, Na N, Zhu X, et al. Estrogenic effect of ginsenoside Rg1 on APP processing in post-menopausal platelets[J]. Platelets,2013,24(1):51.
[4]
Wu J, Pan Z, Wang Z, et al. Ginsenoside Rg1 protection against beta-amyloid peptide-induced neuronal apoptosis via estrogen receptor alpha and glucocorticoid receptor-dependent anti-protein nitration pathway[J]. Neuropharmacology,2012,63(3):349.
Wang Q, Sun L H, Jia W, et al. Comparison of ginsenosides Rg1 and Rb1 for their effects on improving scopolamine-induced learning and memory impairment in mice[J]. Phytother Res, 2010, 24(12):1748.
Zhao H H, Di J, Liu W S, et al. Involvement of GSK3 and PP2A in ginsenoside Rb1\'s attenuation of aluminum-induced tau hyperphosphorylation[J]. Behav Brain Res, 2013, 241:228.
Jiang B, Xiong Z, Yang J, et al. Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus[J]. Br J Pharmacol, 2012, 166(6):1872.
Zhang X, Wang J, Xing Y, et al. Effects of ginsenoside Rg1 or 17beta-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer\'s disease[J]. Neuroscience,2012,220:191.
[21]
Fang F, Chen X, Huang T, et al. Multi-faced neuroprotective effects of ginsenoside Rg1 in an Alzheimer mouse model[J]. Biochim Biophys Acta,2012,1822(2):286.
[22]
Quan Q, Wang J, Li X, et al. Ginsenoside Rg1 decreases Abeta1-42 level by upregulating PPAR gamma and IDE expression in the hippocampus of a rat model of Alzheimer\'s disease[J]. PLoS ONE,2013,8(3):e59155.
Yan J, Liu Q, Dou Y, et al. Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against beta-amyloid peptide-induced human endothelial cells apoptosis[J]. J Ethnopharmacol,2013,147(2):456.
[25]
Xie X, Wang H T, Li C L, et al. Ginsenoside Rb1 protects PC12 cells against beta-amyloid-induced cell injury[J]. Mol Med Rep,2010,3(4):635.
[26]
Zhao R, Zhang Z, Song Y, et al. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3beta pathway in ginsenoside Rb1\'s attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation[J]. J Ethnopharmacol,2011,133(3):1109.
[27]
盛树力.老年性痴呆:从分子生物学到临床诊治[M].北京:科学技术文献出版社,1998:109.
[28]
Yin L M, Wang X, Qian X D, et al. Effects of Panax notoginseng saponins on proliferation and differentiation in NIH3T3 cells[J]. Chin J Integr Med, 2012, 18(8):616.
Jiang Z, Wang Y, Zhang X, et al. Preventive and therapeutic effects of ginsenoside Rb1 for neural injury during cerebral infarction in rats[J]. Am J Chin Med, 2013, 41(2):341.
[33]
Zhu J, Jiang Y, Wu L, et al. Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia[J]. Neuroscience, 2012, 202:342.
[34]
Liang J, Yu Y, Wang B, et al. Ginsenoside Rb1 attenuates oxygen-glucose deprivation-induced apoptosis in SH-SY5Y cells via protection of mitochondria and inhibition of AIF and cytochrome c release[J]. Molecules, 2013, 18(10):12777.
[35]
X Meng, M Wang, X Wang, et al. Suppression of NADPH oxidase-and mitochondrion-derived superoxide by notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways[J]. Free Radical Res,2014,doi:10.3109/10715762.2014.911853.
Xu L, Chen W F, Wong M S. Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson\'s disease through the IGF-I receptor signalling pathway[J]. Br J Pharmacol, 2009, 158(3):738.
Luo F C, Wang S D, Qi L, et al. Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo[J]. J Ethnopharmacol, 2011, 133(2):448.
[40]
Hashimoto R, Yu J, Koizumi H, et al. Ginsenoside Rb1 prevents MPP(+)-induced apoptosis in PC12 cells by stimulating estrogen receptors with consequent activation of ERK1/2, Akt and inhibition of SAPK/JNK, p38 MAPK[J]. Evid Based Complement Alternat Med, 2012,doi:693717.
Xiang H, Liu Y, Zhang B, et al. The antidepressant effects and mechanism of action of total saponins from the caudexes and leaves of Panax notoginseng in animal models of depression[J]. Phytomedicine, 2011, 18(8/9):731.
[43]
Lee S H, Hur J, Lee E H, et al. Ginsenoside Rb1 modulates level of monoamine neurotransmitters in mice frontal cortex and cerebellum in response to immobilization stress[J]. Biomol Ther (Seoul), 2012, 20(5):482.
[44]
Cui J, Jiang L, Xiang H. Ginsenoside Rb3 exerts antidepressant-like effects in several animal models[J]. J Psychopharmacol, 2012, 26(5):697.
Gu B, Nakamichi N, Zhang W S, et al. Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assembly[J]. J Neurosci Res, 2009, 87(9):2145.
[48]
Liang W, Ge S, Yang L, et al. Ginsenosides Rb1 and Rg1 promote proliferation and expression of neurotrophic factors in primary Schwann cell cultures[J]. Brain Res, 2010, 1357:19.
Zong Y, Ai Q L, Zhong L M, et al. Ginsenoside Rg1 attenuates lipopolysaccharide-induced inflammatory responses via the phospholipase C-gamma1 signaling pathway in murine BV-2 microglial cells[J]. Curr Med Chem, 2012, 19(5):770.
[53]
Lee J S, Song J H, Sohn N W, et al. Inhibitory effects of ginsenoside Rb1 on neuroinflammation following systemic lipopolysaccharide treatment in mice[J]. Phytother Res, 2013, 27(9):1270.
Wu P F, Zhang Z, Wang F, et al. Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury[J]. Acta Pharmacol Sin, 2010, 31(12):1523.
Saw C L, Yang A Y, Cheng D C, et al. Pharmacodynamics of ginsenosides: antioxidant activities, activation of Nrf2, and potential synergistic effects of combinations[J]. Chem Res Toxicol, 2012, 25(8):1574.
[59]
Chula S, Hang L, Yinying B, et al. The effects of notoginsenoside R1 on the intestinal absorption of geniposide by the everted rat gut sac model[J]. J Ethnopharmacol, 2012, 142(1):136.
